SGLT2 Inhibitors in Heart Failure
- 7 October 2022
- journal article
- review article
- Published by Elsevier in Heart Failure Clinics
- Vol. 18 (4) , 587-596
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Heart Failure With Mid-Range (Borderline) Ejection FractionJACC: Heart Failure, 2017
- Neurohormonal activation in heart failure with reduced ejection fractionNature Reviews Cardiology, 2016
- Cost-effectiveness Analysis of Sacubitril/Valsartan vs Enalapril in Patients With Heart Failure and Reduced Ejection FractionJAMA Cardiology, 2016
- SGLT2 inhibitors in the management of type 2 diabetesEndocrine, 2016
- Trends in 30-Day Readmission Rates for Patients Hospitalized With Heart FailureCirculation: Heart Failure, 2016
- ACC/AHA Statement on Cost/Value Methodology in Clinical Practice Guidelines and Performance MeasuresJACC, 2014
- 2013 ACCF/AHA Guideline for the Management of Heart FailureJACC, 2013
- Cardiovascular Effects of Erythropoietin2010
- Anemia and Mortality in Heart Failure PatientsJACC, 2008
- Neurohormonal consequences of diuretics in different cardiovascular syndromesEuropean Heart Journal, 1992